WANBURY
|
WANBURY Last 5 Year Cashflow Statement History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit Before Tax | ₹56 Cr | ₹-10 Cr | ₹81 Cr | ₹-12 Cr | ₹65 Cr |
Adjustment | ₹16 Cr | ₹37 Cr | ₹-44 Cr | ₹33 Cr | ₹-41 Cr |
Changes In working Capital | ₹-68 Cr | ₹-6.75 Cr | ₹3.24 Cr | ₹-3.00 Cr | ₹21 Cr |
Cash Flow after changes in Working Capital | ₹4.16 Cr | ₹20 Cr | ₹41 Cr | ₹18 Cr | ₹44 Cr |
Cash Flow from Operating Activities | ₹3.98 Cr | ₹20 Cr | ₹41 Cr | ₹17 Cr | ₹44 Cr |
Cash Flow from Investing Activities | ₹-17 Cr | ₹-8.84 Cr | ₹0.59 Cr | ₹8.04 Cr | ₹64 Cr |
Cash Flow from Financing Activities | ₹15 Cr | ₹-32 Cr | ₹-29 Cr | ₹-17 Cr | ₹-108 Cr |
Net Cash Inflow / Outflow | ₹1.91 Cr | ₹-21 Cr | ₹13 Cr | ₹7.34 Cr | ₹-0.08 Cr |
Opening Cash & Cash Equivalents | ₹1.49 Cr | ₹23 Cr | ₹10 Cr | ₹2.66 Cr | ₹2.74 Cr |
Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - | - | - | - |
Cash & Cash Equivalent of Subsidiaries under liquidations | - | - | - | - | - |
Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - | - | - | - |
Effect of Foreign Exchange Fluctuations | - | - | - | - | - |
Closing Cash & Cash Equivalent | ₹3.40 Cr | ₹1.49 Cr | ₹23 Cr | ₹10 Cr | ₹2.66 Cr |
Compare Cashflow Statement of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹950.9 Cr | 3.2% | 8.8% | 131.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹443,661.0 Cr | -1.8% | 2.7% | 49.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹160,496.0 Cr | -0.2% | -3.4% | 57% | Stock Analytics | |
CIPLA | ₹121,970.0 Cr | -0.7% | 0.6% | 22.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹112,877.0 Cr | -1.8% | 11.3% | 18% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,163.2 Cr | 1.9% | 0.5% | 41.9% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | 3.2% |
8.8% |
131.6% |
SENSEX | 0.7% |
-2% |
9.7% |
You may also like the below Video Courses